The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis

Respiratory Medicine
Caroline H H NicolsonAnne E Holland

Abstract

Inhalation of hypertonic saline (HTS) has short term positive effects on airways clearance in non-cystic fibrosis (CF) bronchiectasis, however its long term effects are unknown. The aim of this study was to determine the effect of HTS 6% on exacerbations, quality of life (QOL) and respiratory function over 12 months in non-CF bronchiectasis. Forty patients were randomised to inhale isotonic saline (IS) 0.9% or HTS 6% daily for 12 months. Participants recorded their symptoms in a daily diary. Quality of life and respiratory function were measured after three, six and 12 months. Number of exacerbations and changes in sputum colonisation were recorded at 12 months. Participants, assessors and clinicians were blinded to group allocation. The exacerbation rate at 12 months was similar in the two groups and similar clinically significant improvements in QOL were seen in both groups. The FEV(1) increased in both groups after six months (mean 90 ml, 95% confidence interval 11-169 ml) with no difference between groups (p = 0.394). The FEF(25-75%) significantly improved at all time points (mean increase at 12 months 187 ml, 69-304 ml) with no difference between groups (p = 0.705). There was a reduction in sputum colonisation in both grou...Continue Reading

References

Dec 1, 1996·American Journal of Respiratory and Critical Care Medicine·A WannerT G O'Riordan
Aug 1, 1997·The European Respiratory Journal·C B WilsonR Wilson
Jul 22, 1999·The European Respiratory Journal·E HoutmeyersM Decramer
Aug 13, 1999·The European Respiratory Journal·C P van der SchansB K Rubin
Oct 25, 2002·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Evangelia DaviskasP T P Bye
May 20, 2003·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yasuhiro ShibuyaPeter J Cole
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Jan 20, 2006·The New England Journal of Medicine·Mark R ElkinsUNKNOWN National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group
Jan 20, 2006·The New England Journal of Medicine·Scott H DonaldsonRichard C Boucher
Mar 3, 2007·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Eleanor BatesSteven M Rowe
Mar 28, 2007·Thorax·J S Elborn, S C Bell
Mar 5, 2008·Current Opinion in Infectious Diseases·Jonathan IlowiteShalinee Chawla
Aug 8, 2008·Chronic Respiratory Disease·J M CourtneyJ S Elborn
Feb 7, 2009·The European Respiratory Journal·M P MurrayA T Hill
Apr 10, 2009·The European Respiratory Journal·M R LoebingerR Wilson
Jun 23, 2009·The European Respiratory Journal·M P MurrayA T Hill
Feb 11, 2010·Respiratory Medicine·Harold ReaKevin O'Donnell
Jul 16, 2010·Thorax·M C PasteurUNKNOWN British Thoracic Society Non-CF Bronchiectasis Guideline Group

❮ Previous
Next ❯

Citations

Aug 1, 2013·American Journal of Respiratory and Critical Care Medicine·Pamela J McShaneMary E Strek
Jul 6, 2014·Archivos de bronconeumología·Casilda OlveiraAdolfo Domenech
Dec 15, 2015·Revue des maladies respiratoires·I Honoré, P-R Burgel
Mar 25, 2015·Expert Opinion on Pharmacotherapy·James D ChalmersStefano Aliberti
Mar 22, 2016·Expert Opinion on Orphan Drugs·M Leigh Anne Daniels, Peadar G Noone
Oct 14, 2014·Expert Opinion on Investigational Drugs·Manjit K SidhuAdam T Hill
Mar 5, 2015·Expert Opinion on Emerging Drugs·Anne B ChangLucas R Hoffman
Feb 10, 2016·Clinics in Chest Medicine·Wael ElMaraachliAngela C C Wang
Sep 30, 2015·Pediatric Pulmonology·Adam J ShapiroUNKNOWN Genetic Disorders of Mucociliary Clearance Consortium
Nov 21, 2015·Paediatric Respiratory Reviews·Deepika PolineniSharon D Dell
Sep 24, 2014·Thorax·Diana BiltonUNKNOWN B-305 Study Investigators
Jul 18, 2015·Respiratory Medicine·Matthew J Martin, Tim W Harrison
Jun 13, 2015·American Journal of Respiratory and Critical Care Medicine·David E GriffithRichard J Wallace
Jan 15, 2014·Expert Opinion on Pharmacotherapy·Manjit K SidhuAdam T Hill
Jul 16, 2013·Revista portuguesa de pneumologia·A AmorimP Azevedo
May 30, 2012·Clinics in Chest Medicine·Lizzie J FludeDiana Bilton
Apr 12, 2017·Respirology : Official Journal of the Asian Pacific Society of Respirology·Benjamin J TarrantAnne E Holland
May 26, 2017·Expert Review of Respiratory Medicine·Danielle F Wurzel, Anne B Chang
Feb 18, 2017·Current Opinion in Pulmonary Medicine·Hani Abo-Leyah, James D Chalmers
Nov 4, 2017·Medical Sciences : Open Access Journal·Caroline H NicolsonAnnemarie L Lee
Jun 8, 2018·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Beatriz Herrero-CortinaEva Polverino
May 29, 2018·Expert Review of Respiratory Medicine·Rodrigo AthanazioMiguel Ángel Martínez-García
Jul 18, 2018·Therapeutic Advances in Respiratory Disease·Luis MáizMiguel A Martínez-García
May 13, 2014·The Cochrane Database of Systematic Reviews·Anna HartIain Crossingham
Dec 14, 2018·Thorax·Adam T HillMichael R Loebinger
Jan 17, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Katherine O'NeillJudy M Bradley
Mar 21, 2015·The European Respiratory Journal·James D ChalmersFrancesco Blasi
Feb 25, 2017·The European Respiratory Journal·Claudia E KuehniHelene E Kobbernagel
Jun 10, 2017·The European Respiratory Journal·Adam T HillUNKNOWN EMBARC/BRR definitions working group
Mar 16, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Megan L CrichtonJames D Chalmers
Aug 9, 2019·Therapeutic Advances in Respiratory Disease·Luis Máiz Carro, Miguel A Martínez-García
Aug 15, 2019·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Mônica Corso PereiraRosemeri Maurici
Mar 13, 2020·Therapeutic Advances in Respiratory Disease·Sherstin T Lommatzsch
Aug 7, 2017·Expert Review of Respiratory Medicine·Michael F PapacostasSusan Hupp
Jun 13, 2013·International Journal of Immunopathology and Pharmacology·D SnijdersA Barbato
Oct 8, 2014·British Journal of Hospital Medicine·Ricardo J José, Jeremy S Brown
Sep 30, 2019·The European Respiratory Journal·Arietta Spinou, James D Chalmers
May 12, 2017·F1000Research·Usma Koser, Adam Hill
Oct 3, 2020·Cells·Luis Máiz Carro, Miguel A Martínez-García
Feb 19, 2015·Current Opinion in Infectious Diseases·Vanessa L Yap, Mark L Metersky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.